RAC — Race Oncology Balance Sheet
0.000.00%
- AU$173.71m
- AU$154.93m
- AU$0.83m
Annual balance sheet for Race Oncology, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.73 | 9.32 | 33.5 | 21.5 | 17.2 |
Net Total Receivables | 0.049 | 0.128 | 0.062 | 1.7 | 0.106 |
Prepaid Expenses | |||||
Total Current Assets | 2 | 10.6 | 34.2 | 23.5 | 17.4 |
Net Intangible Assets | |||||
Total Assets | 5.93 | 14.2 | 37.5 | 26.6 | 20.2 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.244 | 0.523 | 1.42 | 1.15 | 1.87 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.244 | 0.523 | 1.42 | 1.15 | 1.92 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5.69 | 13.7 | 36.1 | 25.5 | 18.3 |
Total Liabilities & Shareholders' Equity | 5.93 | 14.2 | 37.5 | 26.6 | 20.2 |
Total Common Shares Outstanding |